Aveir DR i2i Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 464 participants.
Also called NCT05252702
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 464 participants
- Sponsor
- Registry
-
NCT05252702
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Austria, Belgium, Canada, Czechia, France, Hong Kong SAR China, Italy, Japan, Netherlands, Spain, Taiwan, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT05252702. Allocation not applicable; no masking; primary purpose treatment. Start 2022-02-02 (actual); primary completion 2023-08-02 (actual). Results posted on 2024-11-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aveir DR i2i Study
- Condition
- Cardiac Pacemaker, Artificial
- Condition
- Cardiac Rhythm Disorder
- Condition
- Bradycardia
- Intervention (Device)
- Aveir DR Leadless Pacemaker System
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct05252702- Content hash
e517d6fc9031d0772ad042f95add4b0f89b2e43e66b3c5637308220b2dc79273